Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024February 29, 2024 Zelira Therapeutics was hit with a A$30.7m impairment charge in the first half of the financial […]
Company news: LGP/Reset; Melodiol; AusCann; Elixinol by Martin Lane February 21, 2024February 21, 2024
LGP reports sales downturn but predicts a ‘re-rating’ of Australian firms amid US rescheduling report by Steve Jones January 31, 2024February 1, 2024
Company news: Clever Leaves; Cronos/Vitura; InhaleRX; Emyria; CannMart/Aura Therapeutics; Cann Group; Greenfern Industries; LGP/Reset Mind Sciences by Steve Jones and Martin Lane January 16, 2024January 17, 2024
Little Green Pharma sees 37% revenue lift as CEO predicts ‘inevitable consolidation’ by Steve Jones December 1, 2023December 7, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Almost 150,000 kilograms of cannabis destroyed in Danish cull by Martin Lane September 21, 2023September 22, 2023